Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors.
EMBO Mol Med. 2023 Oct 11;15(10):e17367. doi: 10.15252/emmm.202217367. Epub 2023 Aug 17.
EMBO Mol Med. 2023.
PMID: 37587872
Free PMC article.
MYC Promotes Tyrosine Kinase Inhibitor Resistance in ROS1-Fusion-Positive Lung Cancer.
Iyer SR, Odintsov I, Schoenfeld AJ, Siau E, Mattar MS, de Stanchina E, Khodos I, Drilon A, Riely GJ, Ladanyi M, Somwar R, Davare MA.
Iyer SR, et al.
Mol Cancer Res. 2022 May 4;20(5):722-734. doi: 10.1158/1541-7786.MCR-22-0025.
Mol Cancer Res. 2022.
PMID: 35149545
Free PMC article.
Item in Clipboard
Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.
Davare MA, Henderson JJ, Agarwal A, Wagner JP, Iyer SR, Shah N, Woltjer R, Somwar R, Gilheeney SW, DeCarvalo A, Mikkelson T, Van Meir EG, Ladanyi M, Druker BJ.
Davare MA, et al. Among authors: iyer sr.
Clin Cancer Res. 2018 Dec 15;24(24):6471-6482. doi: 10.1158/1078-0432.CCR-18-1052. Epub 2018 Aug 31.
Clin Cancer Res. 2018.
PMID: 30171048
Free PMC article.
Item in Clipboard
Cite
Cite